DXCM Stock Escalating: Is the Pharma Stock Profitable? 

DXCM surged by 9.99%, and in the last 6 months, the prices of stocks ascended by over 33%.  According to WHO 420 million people globally have Diabetes.  Dexcom, Inc. (NASDAQ: DXCM), founded in 1999 an...

Dexcom,Inc. (DXCM): Is the Pharma Stock Profitable?

Registered at 16.27% higher quarterly revenue of $811.79 million.  DXCM is trading premium at a Forward P/E ratio of 101.49. The next earning release is expected to be $0.26, with year-to-year gr...

DexCom stock drops 17% after company’s Q2 miss

DexCom Inc. DXCM, +1.39% shares fell nearly 17% in the extended session Thursday after the maker of glucose monitoring systems missed analyst expectations for its first quarter and tweaked higher its ...